Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

Comparative Contraception: Reversible and Permanent Options




On Demand Sessions:

Expiration Date Presenter Are you seeking credit?
September 30, 2017 Anne A. Moore, DNP, APN-BC, FAANP Review webinar for CME/CE credit*

Review webinar without credit

*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.

This is an internet-based activity that should take one hour to complete. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.

Click here to review the Q&A session from the June 9th, 2015 webinar presentation.
Click here to review the Q&A session from the July 29th, 2015 webinar presentation.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

  • Describe the benefits, risks, and side effects of long-acting reversible and permanent contraceptive methods.
  • Identify potential candidates for long-acting reversible and permanent contraception.
  • Discuss myths and other potential barriers to the use of long-acting reversible and permanent contraception.
  • Describe shared decision making that helps women choose a contraceptive method.
  • Identify sources of evidence-based information for patients on long-term and permanent contraception.

Accreditation Information

Nurse Practitioners and Nurses: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. This live activity is approved for 1.0 contact hour.

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit™.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from Bayer and Teva Pharmaceuticals.

Target Audience

This activity is designed for physicians, nurse midwives, nurse practitioners, physician assistants, students, educators, and researchers who focus on reproductive health care, family practice or internal medicine.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

  • Linda Dominguez, RN-C, NP (planner) is a consultant and master trainer for both Activis and Medicine 360.
  • Mark Hathaway, MD, MPH (planner) is a consultant for Afaxys, Actavis, ContraMed, and Medicine 360, and a trainer for Merck Nexplanon.
  • Anne Moore, DNP, APRN, FAANP (planner/faculty) is a speaker for Activis and Pfizer.
  • Lee Shulman, MD, FACOG, FACMG (planner) is a speaker and/or consultant for Activis, Teva, Merck, Bayer, Shionogi, Sequenom, Natera, Quest, and Roche Labs.  

ARHP Staff/Consultant Disclosures

  • Diane Shannon, MD (medical writer) and Rana Suliman, MPH (ARHP program manager) have nothing to disclose.

Back